Studies related to Cognitive Decline and DMAE

Effect Of Six Months Of Treatment With V0191 In Patients With Suspected Prodromal Alzheimer's Disease

Effect None
Trial Design Double blind
Trial Length n/a
Number of Subjects 241
Sex Both Genders
Age Range 65+
Notes for this study:
No significant effect of 1500mg DMAE pyroglutamate over 24 weeks in persons with cognitive decline